Cargando…
Quality of drug-resistant tuberculosis care: Gaps and solutions
Drug-resistant forms of tuberculosis (DR-TB) are a significant cause of global morbidity and mortality and the treatment of DR-TB is characterized by long and toxic regimens that result in low rates of cure. There are few formal studies documenting the quality of DR-TB treatment services provided gl...
Autores principales: | Udwadia, Zarir, Furin, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830144/ https://www.ncbi.nlm.nih.gov/pubmed/31720427 http://dx.doi.org/10.1016/j.jctube.2019.100101 |
Ejemplares similares
-
Optimal management of drug-resistant tuberculosis: Can India lead the way?
por: Masini, Tiziana, et al.
Publicado: (2023) -
India should speed up access to bedaquiline-based all-oral regimens, not procrastinate further
por: Udwadia, Zarir F, et al.
Publicado: (2021) -
Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
por: Udwadia, Zarir F., et al.
Publicado: (2014) -
Disseminated tuberculosis with immune thrombocytopenic purpura
por: Dagaonkar, Rucha S., et al.
Publicado: (2012) -
New treatments for Drug Resistant TB: Past imperfect, future bright
por: Udwadia, Zarir F., et al.
Publicado: (2023)